Cargando…

Mitochondrial Molecular Pathophysiology of Nonalcoholic Fatty Liver Disease: A Proteomics Approach

Nonalcoholic fatty liver disease (NAFLD) is a chronic liver condition that can progress to nonalcoholic steatohepatitis, cirrhosis and cancer. It is considered an emerging health problem due to malnourishment or a high-fat diet (HFD) intake, which is observed worldwide. It is well known that the hep...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nuño-Lámbarri, Natalia, Barbero-Becerra, Varenka J., Uribe, Misael, Chávez-Tapia, Norberto C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4813145/ https://www.ncbi.nlm.nih.gov/pubmed/26999105 http://dx.doi.org/10.3390/ijms17030281

Ejemplares similares

Prebiotics and Probiotics: Therapeutic Tools for Nonalcoholic Fatty Liver Disease
por: Mijangos-Trejo, Alejandra, et al.
Publicado: (2023)

Role of bioactive fatty acids in nonalcoholic fatty liver disease
por: Juárez-Hernández, Eva, et al.
Publicado: (2016)

The diagnostic and initial approach of the patient with non-alcoholic fatty liver disease: role of the primary care provider
por: Salva-Pastor, Nicolás, et al.
Publicado: (2019)

Inulin Improves Diet-Induced Hepatic Steatosis and Increases Intestinal Akkermansia Genus Level
por: Pérez-Monter, Carlos, et al.
Publicado: (2022)

Nuclear Receptors in Nonalcoholic Fatty Liver Disease
por: López-Velázquez, Jorge A., et al.
Publicado: (2012)

Understanding the Relationship between Nonalcoholic Fatty Liver Disease and Thyroid Disease
por: Vidal-Cevallos, Paulina, et al.
Publicado: (2023)

Cross-sectional pilot study to assess primary healthcare workers’ knowledge of nonalcoholic fatty liver disease in a marginalized community in Mexico
por: Vidal-Cevallos, Paulina, et al.
Publicado: (2021)

Understanding the Role of Metabolic Syndrome as a Risk Factor for Hepatocellular Carcinoma
por: Chavez-Tapia, Norberto C, et al.
Publicado: (2022)

The fibrogenic process and the unleashing of acute-on-chronic liver failure
por: López-Sánchez, Guillermo Nahúm, et al.
Publicado: (2020)

Pathophysiological, Molecular and Therapeutic Issues of Nonalcoholic Fatty Liver Disease: An Overview
por: Marchisello, Simona, et al.
Publicado: (2019)

The Role of Dendritic Cells in Fibrosis Progression in Nonalcoholic Fatty Liver Disease
por: Almeda-Valdes, Paloma, et al.
Publicado: (2015)

Fatty Pancreas: Linking Pancreas Pathophysiology to Nonalcoholic Fatty Liver Disease
por: Rugivarodom, Manus, et al.
Publicado: (2022)

Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease
por: Masarone, Mario, et al.
Publicado: (2018)

COVID-19: Current Status in Gastrointestinal, Hepatic, and Pancreatic Diseases—A Concise Review
por: Aquino-Matus, Jorge, et al.
Publicado: (2022)

Hypothyroidism and Nonalcoholic Fatty Liver Disease: Pathophysiological Associations and Therapeutic Implications
por: Kizivat, Tomislav, et al.
Publicado: (2020)

Corrigendum to “Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease”
por: Masarone, Mario, et al.
Publicado: (2021)

Incremental levels of diagnostic information incentivize health-seeking in non-alcoholic fatty liver: a randomized clinical trial
por: Chavez-Tapia, Norberto C., et al.
Publicado: (2022)

Effect of intracellular lipid accumulation in a new model of non-alcoholic fatty liver disease
por: Chavez-Tapia, Norberto C, et al.
Publicado: (2012)

Nonalcoholic fatty liver disease and atrial fibrillation: possible pathophysiological links and therapeutic interventions
por: Haghbin, Hossein, et al.
Publicado: (2020)

Prophylactic Activated Recombinant Factor VII in Liver Resection and Liver Transplantation: Systematic Review and Meta-Analysis
por: Chavez-Tapia, Norberto C., et al.
Publicado: (2011)

The Mitochondrial Trigger in an Animal Model of Nonalcoholic Fatty Liver Disease
por: Chimienti, Guglielmina, et al.
Publicado: (2021)

Clinical characterization and proteomic profiling of lean nonalcoholic fatty liver disease
por: Jiang, Yuanye, et al.
Publicado: (2023)

Nonalcoholic fatty liver disease and alcohol-related liver disease: From clinical aspects to pathophysiological insights
por: Ikejima, Kenichi, et al.
Publicado: (2020)

Promising diagnostic biomarkers of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: From clinical proteomics to microbiome
por: Castillo-Castro, Carolina, et al.
Publicado: (2021)

Role of mitochondrial quality control in the pathogenesis of nonalcoholic fatty liver disease
por: Li, Ruibing, et al.
Publicado: (2020)

Mitochondrial Dysfunction Plays Central Role in Nonalcoholic Fatty Liver Disease
por: Ramanathan, Raghu, et al.
Publicado: (2022)

Hyperphosphorylation of hepatic proteome characterizes nonalcoholic fatty liver disease in S-adenosylmethionine deficiency
por: Robinson, Aaron E., et al.
Publicado: (2023)

Mitochondrial proteome design: From molecular identity to pathophysiological regulation
por: Zhang, Jun, et al.
Publicado: (2012)

Nonalcoholic Fatty Liver Disease
por: Filipović, Branka, et al.
Publicado: (2018)

Nonalcoholic fatty liver disease
por: Bebawi, Emmanuel, et al.
Publicado: (2023)

A Pathophysiologic Approach Combining Genetics and Insulin Resistance to Predict the Severity of Nonalcoholic Fatty Liver Disease
por: Danford, Christopher J., et al.
Publicado: (2018)

Magnetic Resonance-Based Assessments Better Capture Pathophysiologic Profiles and Progression in Nonalcoholic Fatty Liver Disease
por: Choi, Seung Joon, et al.
Publicado: (2021)

Nonalcoholic fatty liver disease: molecular mechanisms for the hepatic steatosis
por: Koo, Seung-Hoi
Publicado: (2013)

Nonalcoholic fatty liver disease: molecular pathways and therapeutic strategies
por: Huang, Yue Ye, et al.
Publicado: (2013)

Recent Progress in the Molecular Imaging of Nonalcoholic Fatty Liver Disease
por: Wegrzyniak, Olivia, et al.
Publicado: (2021)

Regulation of mitochondrial trifunctional protein modulates nonalcoholic fatty liver disease in mice
por: Nassir, Fatiha, et al.
Publicado: (2018)

Progress in Nonalcoholic Fatty Liver Disease: SIRT Family Regulates Mitochondrial Biogenesis
por: Zeng, Chuanfei, et al.
Publicado: (2022)

Cadmium promotes nonalcoholic fatty liver disease by inhibiting intercellular mitochondrial transfer
por: Sun, Jian, et al.
Publicado: (2023)

Rodent Models of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
por: Imajo, Kento, et al.
Publicado: (2013)

A Review of the Epidemiology, Pathophysiology, and Efficacy of Anti-diabetic Drugs Used in the Treatment of Nonalcoholic Fatty Liver Disease
por: Manka, Paul P., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cq8mc3q2ahmheb32vlghbcl9f0